Biosimilar Growth Hormones Global Market Report 2024

Description

Biosimilar growth hormone is a peptide hormone vital for stimulating cellular regeneration, cell division, and overall growth in humans and other organisms. Its significance lies in its role in advancing human development, serving as a targeted mitogen affecting specific cell types.

These hormones are administered through various routes such as intravenous, subcutaneous, intramuscular, and oral methods. Intravenous administration involves the injection of fluids, medications, or nutrients directly into a patient's vein. Applications for biosimilar growth hormones encompass treating conditions like growth hormone deficiency, Turner syndrome, idiopathic short stature, Prader-Willi syndrome, among others. These treatments are available through diverse distribution channels including hospital and retail pharmacies, online pharmacy platforms, and specialty clinics.

The biosimilar growth hormone market research report is one of a series of new reports from The Business Research Company that provides biosimilar growth hormone market statistics, including biosimilar growth hormone industry global market size, regional shares, competitors with a biosimilar growth hormone market share, detailed biosimilar growth hormone market segments, market trends and opportunities, and any further data you may need to thrive in the biosimilar growth hormone industry. This biosimilar growth hormone market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The biosimilar growth hormones market size has grown strongly in recent years. It will grow from $0.76 billion in 2023 to $0.82 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth observed in the historical period can be attributed to several factors. These include a growing demand for growth hormones, the expiration of patents enabling the development of biosimilar alternatives, the availability of clinical evidence supporting their efficacy, and an increase in clinical trials aimed at exploring their applications and benefits. These factors collectively contributed to the expansion and development of biosimilar growth hormones during this period.

The biosimilar growth hormones market size is expected to see strongly grown in the next few years. It will grow to $1.19 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. Anticipated growth in the forecast period is expected to stem from several key factors. These include the focus on pediatric growth disorders, the widening scope of indications for biosimilar treatments, a rise in diagnoses due to increased awareness, and the recognition of biosimilar options among healthcare providers and patients.

The global biosimilar growth hormone market is experiencing growth due to the increasing incidence of growth hormone deficiency among children. This deficiency, caused by pituitary or hypothalamic damage, affects about 1 in every 3,800 babies and can also occur later due to various factors like brain tumors, surgeries, or infections. The rising number of affected children drives the demand for biosimilar growth hormones.

The prevalence of chronic diseases globally is anticipated to fuel the biosimilar growth hormone market. Chronic conditions, while not curable, are manageable, and biosimilar growth hormones have proven effective, especially for children with growth disorders and chronic kidney disease. As projected by the National Library of Medicine, the US will witness a significant 99.5% rise in individuals aged 50 and above with chronic illnesses by 2050, soaring from 71.522 million in 2020, boosting the demand for biosimilar growth hormones.

The implementation of recombinant DNA technology in the biosimilar growth hormone sector is a burgeoning trend. Notably, Pfizer Inc.'s initiation of a Phase III clinical trial utilizing somatropin, a growth hormone developed via recombinant DNA technology, emphasizes this. The trial assesses the efficacy and safety of somatropin for addressing growth hormone deficiency in children, focusing on a cohort with Prader-Willi Syndrome.

Key players in the biosimilar growth hormone market are introducing innovative products like NGENLA to enhance market profitability. Pfizer Inc.'s recent FDA approval for NGENLA, a once-weekly administered human growth hormone analog, targets pediatric patients aged three and older experiencing growth failure due to inadequate secretion of their own growth hormone. This product, slated for availability in the US from August 2023, aims to address growth hormone deficiencies more conveniently.

In October 2023, the US-based biotechnology company Amgen completed the acquisition of Horizon Therapeutics plc for a substantial $27.8 billion. This strategic move aligns with Amgen's overarching goal of providing innovative and impactful medications to patients dealing with severe illnesses. The acquisition notably includes Horizon's pharmaceutical portfolio, encompassing Tepezza, designed to address thyroid eye disease, Krystexxa, targeting chronic refractory gout, and Uplizna, intended for neuromyelitis optica spectrum disorder.

Major companies operating in the biosimilar growth hormones market include Amega Biotech, Biosidus S.A., Eli Lilly and Company, Ferring Pharmaceuticals, Genetech Inc., Merck & Co. Inc., Novartis AG, Novo Nordisk A/S, Sanofi S.A., USV Private Limited, Zhongshan Hygene Biopharm Co. Ltd., Biopartners And LG Chem, Boehringer Ingelheim International GmbH, Celltrion Inc., Coherus BioSciences Inc., Daiichi Sankyo Company Ltd., Dr. Reddy's Laboratories Ltd., Gedeon Richter Plc., Genor Biopharma Co. Ltd., GenScript Biotech Corporation, Hetero Drugs Limited, Intas Pharmaceuticals Ltd., LG Chem Ltd., Lupin Limited, Mabion S.A., Mundipharma International Limited, Oncobiologics Inc., Panacea Biotec Limited, Pfenex Inc., PlantForm Corporation

North America was the largest region in the biosimilar growth hormone market in 2023. The Middle East is expected to be the fastest-growing region in the biosimilar growth hormones market report during the forecast period. The regions covered in the biosimilar growth hormones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the biosimilar growth hormones market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The biosimilar growth hormone market consists of sales of teriparatide, follitropin alfa, insulin, and somatropin. Values in this market are 'factory gate values,' that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biosimilar Growth Hormones Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biosimilar growth hormones market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biosimilar growth hormones? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biosimilar growth hormones market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Route Of Administration: Intravenous; Subcutaneous; Intramuscular; Oral
2) By Application: Growth Hormone Deficiency; Turner Syndrome; Idiopathic Short Stature; Prader Willi Syndrome; Other Applications
3) By Distribution Channel: Hospital And Retail Pharmacy; Online Pharmacy/ePharmacy; Specialty Clinics
Companies Mentioned: Amega Biotech; Biosidus S.A.; Eli Lilly and Company; Ferring Pharmaceuticals; Genetech Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r13194

1. Executive Summary

2. Biosimilar Growth Hormones Market Characteristics

3. Biosimilar Growth Hormones Market Trends And Strategies

4. Biosimilar Growth Hormones Market - Macro Economic Scenario

4.1. Impact Of High Inflation On the Market
4.2. Ukraine-Russia War Impact On the Market
4.3. COVID-19 Impact On the Market

5. Global Biosimilar Growth Hormones Market Size and Growth

5.1. Global Biosimilar Growth Hormones Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Biosimilar Growth Hormones Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Biosimilar Growth Hormones Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Biosimilar Growth Hormones Market Segmentation

6.1. Global Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Intravenous
Subcutaneous
Intramuscular
Oral
6.2. Global Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Growth Hormone Deficiency
Turner Syndrome
Idiopathic Short Stature
Prader Willi Syndrome
Other Applications
6.3. Global Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospital And Retail Pharmacy
Online Pharmacy/ePharmacy
Specialty Clinics

7. Biosimilar Growth Hormones Market Regional And Country Analysis

7.1. Global Biosimilar Growth Hormones Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Biosimilar Growth Hormones Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Biosimilar Growth Hormones Market

8.1. Asia-Pacific Biosimilar Growth Hormones Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Biosimilar Growth Hormones Market

9.1. China Biosimilar Growth Hormones Market Overview
9.2. China Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Biosimilar Growth Hormones Market

10.1. India Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Biosimilar Growth Hormones Market

11.1. Japan Biosimilar Growth Hormones Market Overview
11.2. Japan Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Biosimilar Growth Hormones Market

12.1. Australia Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Biosimilar Growth Hormones Market

13.1. Indonesia Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Biosimilar Growth Hormones Market

14.1. South Korea Biosimilar Growth Hormones Market Overview
14.2. South Korea Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Biosimilar Growth Hormones Market

15.1. Western Europe Biosimilar Growth Hormones Market Overview
15.2. Western Europe Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Biosimilar Growth Hormones Market

16.1. UK Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Biosimilar Growth Hormones Market

17.1. Germany Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Biosimilar Growth Hormones Market

18.1. France Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Biosimilar Growth Hormones Market

19.1. Italy Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Biosimilar Growth Hormones Market

20.1. Spain Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Biosimilar Growth Hormones Market

21.1. Eastern Europe Biosimilar Growth Hormones Market Overview
21.2. Eastern Europe Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Biosimilar Growth Hormones Market

22.1. Russia Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Biosimilar Growth Hormones Market

23.1. North America Biosimilar Growth Hormones Market Overview
23.2. North America Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Biosimilar Growth Hormones Market

24.1. USA Biosimilar Growth Hormones Market Overview
24.2. USA Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Biosimilar Growth Hormones Market

25.1. Canada Biosimilar Growth Hormones Market Overview
25.2. Canada Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Biosimilar Growth Hormones Market

26.1. South America Biosimilar Growth Hormones Market Overview
26.2. South America Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Biosimilar Growth Hormones Market

27.1. Brazil Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Biosimilar Growth Hormones Market

28.1. Middle East Biosimilar Growth Hormones Market Overview
28.2. Middle East Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Biosimilar Growth Hormones Market

29.1. Africa Biosimilar Growth Hormones Market Overview
29.2. Africa Biosimilar Growth Hormones Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Biosimilar Growth Hormones Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Biosimilar Growth Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Biosimilar Growth Hormones Market Competitive Landscape And Company Profiles

30.1. Biosimilar Growth Hormones Market Competitive Landscape
30.2. Biosimilar Growth Hormones Market Company Profiles
- 30.2.1. Amega Biotech
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Biosidus S.A.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Eli Lilly and Company
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Ferring Pharmaceuticals
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Genentech Inc
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Biosimilar Growth Hormones Market Competitive Benchmarking

32. Global Biosimilar Growth Hormones Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Biosimilar Growth Hormones Market

34. Biosimilar Growth Hormones Market Future Outlook and Potential Analysis

34.1 Biosimilar Growth Hormones Market In 2028 - Countries Offering Most New Opportunities
34.2 Biosimilar Growth Hormones Market In 2028 - Segments Offering Most New Opportunities
34.3 Biosimilar Growth Hormones Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer